Novelion Therapeutics Inc. (NASDAQ:NVLN)

CAPS Rating: 1 out of 5

A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.

Caps

How do you think NVLN will perform against the market?

Add Stock to CAPS Watchlist

All Players

112 Outperform
40 Underperform
 

All-Star Players

13 Outperform
16 Underperform
 

Wall Street

6 Outperform
0 Underperform
 

Top NVLN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

BuffySoro (38.51)
Submitted January 03, 2009

I picked this because of the favorable prospects of the industry, and this looks like a cheap diamond among expensive pebbles.

NetscribeHealthC (69.27)
Submitted March 12, 2007

QLT Inc. is a global biopharmaceutical company specializing in developing treatments for eye diseases as well as dermatological and urological conditions. The company along with its subsidiaries has expertise in the discovery, development and… More

NVLN VS S&P 500 (SPY)

Fools bullish on NVLN are also bullish on:

Fools bearish on NVLN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NVLN.

Recs

0
Member Avatar SmartAce (99.94) Submitted: 9/13/2017 2:32:57 PM : Underperform Start Price: $6.92 NVLN Score: +45.80

After the machine uprising, robots in the club will dance "The Human" by compulsively overeating and playing with their phones on the toilet.

Recs

0
Member Avatar DigitalDisco (87.54) Submitted: 12/19/2016 12:35:24 PM : Underperform Start Price: $8.99 NVLN Score: +70.43

reverse split

Recs

0
Member Avatar oscillation (75.20) Submitted: 12/31/2015 1:15:57 PM : Outperform Start Price: $13.25 NVLN Score: -96.24

nev

Leaderboard

Find the members with the highest scoring picks in NVLN.

Score Leader

kozonoquantity

kozonoquantity (< 20) Score: +263.73

woo

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
BLOWKE < 20 10/27/2008 Underperform 3W $5.60 -28.23% +207.44% +235.67 0 Comment
BS3000 24.76 2/5/2010 Underperform 5Y $11.69 -65.62% +143.52% +209.13 0 Comment
belfairinvestor 28.83 12/18/2009 Underperform 5Y $12.29 -67.28% +137.66% +204.94 0 Comment
kaleidescopic 21.51 9/6/2011 Underperform 3Y $18.02 -77.69% +127.08% +204.77 0 Comment
FreeMortal 28.67 12/16/2009 Underperform 5Y $12.44 -67.69% +132.15% +199.83 0 Comment
inkyprinter 97.98 8/28/2006 Underperform 1Y $19.75 -79.64% +113.56% +193.20 0 Comment
iceyberg < 20 8/23/2006 Underperform 1Y $19.51 -79.40% +112.67% +192.06 0 Comment
ethicalfool 85.32 9/1/2006 Underperform 3Y $19.85 -79.75% +111.16% +190.90 1 Comment
Plando 69.07 10/4/2006 Underperform 1Y $20.03 -79.93% +107.34% +187.27 0 Comment
gillau 82.98 10/9/2006 Underperform 1Y $20.47 -80.36% +104.45% +184.81 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRothCapital 72.46 6/9/2015 Outperform NS $20.60 -80.49% +24.62% -105.10 0 Comment
TrackCKCooper < 20 9/2/2010 Outperform NS $15.02 -73.24% +138.93% -212.16 0 Comment
TrackRothCapital 72.46 4/22/2010 Outperform NS $33.35 +26.24% +13.01% +13.22 5/3/2011 @ $42.10 0 Comment
TrackRBCCapMkts 88.57 4/24/2008 Outperform NS $9.96 -59.65% +96.56% -156.21 0 Comment
TrackCarisandCo 91.32 1/24/2008 Outperform NS $19.75 -34.18% -1.79% -32.39 3/13/2008 @ $13.00 0 Comment
TrackBMOCapital < 20 1/22/2008 Outperform NS $9.73 -58.69% +112.81% -171.50 0 Comment
TrackSoros 88.75 9/30/2007 Outperform NS $14.69 -72.63% +78.37% -151.00 1 Comment
TrackBrandes < 20 9/30/2007 Outperform NS $14.69 -72.63% +78.37% -151.00 2 Comments
TrackBMOCapital < 20 10/31/2006 Outperform NS $42.50 +11.18% +5.36% +5.82 2/20/2007 @ $47.25 0 Comment

Featured Broker Partners